Fig. 2From: Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single centerTime from regorafenib administration of factors (a) Child–Pugh classification, (b) ECOG PS, (c) NLR, (d) combined therapy, and (e) combined therapy modeBack to article page